Abstract:In this investigation, we aimed to address the pressing challenge of treating osteosarcoma, a prevalent and difficult-to-treat form of cancer. To achieve this, we developed a quantitative structure-activity relationship (QSAR) model focused on a specific class of compounds called 2-Phenyl-3-(pyridin-2-yl) thiazolidin-4-one derivatives. A set of 39 compounds was thoroughly examined, with 31 compounds assigned to the training set and 8 compounds allocated to the test set randomly. The goal was to predict the IC50 value of these compounds accurately. To optimize the compounds and construct predictive models, we employed a heuristic method of the CODESSA program. In addition to a linear model using four carefully selected descriptors, we also developed a nonlinear model using the gene expression programming method. The heuristic method resulted in correlation coefficients (R 2) of 0.603, 0.482, and 0.107 for R2 cv and S2, respectively. On the other hand, the gene expression programming method achieved higher R 2 and S2 values of 0.839 and 0.037 in the training set, and 0.760 and 0.157 in the test set, respectively. Both methods demonstrated excellent predictive performance, but the gene expression programming method exhibited greater consistency with experimental values. The successful nonlinear model generated through gene expression programming shows promising potential for designing targeted drugs to combat osteosarcoma effectively. This approach offers a valuable tool for optimizing compound selection and guiding future drug discovery efforts in the battle against osteosarcoma.

Improved Gene Expression Programming and Its Application to QSAR

Qsar Models for the Dermal Penetration of Polycyclic Aromatic Hydrocarbons Based on Gene Expression Programming

Predicting the activity of drugs for a group of imidazopyridine anticoccidial compounds.

QSAR Study on Estrogenic Activity of Structurally Diverse Compounds Using Generalized Regression Neural Network

Quantitative Structure–activity Relationship: Promising Advances in Drug Discovery Platforms

QSPR Model for Predicting Retention Time Basis on Gene Expression Programming

QSAR study on quinolone carboxylic acids as HIV-1 integrase inhibitors based on GEPMS algorithm

Applications of Genetic Algorithms on the Structure–activity Correlation Study of a Group of Non-Nucleoside HIV-1 Inhibitors

Enhanced QSAR model performance by integrating structural and gene expression information.

Application Of Genetic Algorithm To The Qsar Research Of Pyrrolobenzothiazepinones And Pyrrolobenzoxazepinones-Novel And Specific Non-Nucleoside Hiv-1 Reverse Transcription Inhibitors

QSAR study of thiocarbamates as non-nucleoside HIV-1 reverse transcriptase in hibitors

Prediction of the Aquatic Toxicity of Aromatic Compounds to Tetrahymena Pyriformis Through Support Vector Regression

Multi-target QSAR study in the analysis and design of HIV-1 inhibitors

Boosting: An Ensemble Learning Tool for Compound Classification and QSAR Modeling

QSAR study of fiavonoids derivatives as p56lck protein tyrosine kinase inhibitors using GA-SVM

QSAR Study of Carboxylic Acid Derivatives As HIV-1 Integrase Inhibitors

QSAR Studies on 1-Aryl-tetrahydroisoquinoline Analogs As Active Anti-HIV Agents Based on PSO-v-SVM

Using support vector regression for QSAR study on the aldose reductase inhibitory activity of some flavones

QSAR Studies of Imidazopyridine Derivatives As Et-PKG Inhibitors Using the PSO-SVM Approach

A novel non-linear approach for establishing a QSAR model of a class of 2-Phenyl-3-(pyridin-2-yl) thiazolidin-4-one derivatives

Quantitative Structure–activity Relationship Study of Influenza Virus Neuraminidase A/PR/8/34 (H1N1) Inhibitors by Genetic Algorithm Feature Selection and Support Vector Regression